CERo Therapeutics Holdings, Inc. (CERO) stock
CEROOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CEROW
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap $253.05KP/E –Yield 172833.33%
CERo Therapeutics cash
Cash and short-term investments held at the end of each period.
CERo Therapeutics's cash was $862.76K at Jun 30, 2026. For fiscal 2025 it was $1.66M, down 50.0% from the year before. The highest annual figure on record is $3.33M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.66M | -50.0% |
| FY2024 | Dec 31, 2024 | $3.33M | +107.8% |
| FY2023 | Dec 31, 2023 | $1.60M | +236.5% |
| FY2022 | Dec 31, 2022 | $475.87K | -56.7% |
| FY2021 | Dec 31, 2021 | $1.10M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $862.76K | -73.3% |
| Q1 FY2026 | Mar 31, 2026 | $857.49B | +16813409.8% |
| Q4 FY2025 | Dec 31, 2025 | $1.66M | -50.0% |
| Q3 FY2025 | Sep 30, 2025 | $1.90M | +97.1% |
| Q2 FY2025 | Jun 30, 2025 | $3.23M | +234.9% |
| Q1 FY2025 | Mar 31, 2025 | $5.10M | -99.5% |
| Q4 FY2024 | Dec 31, 2024 | $3.33M | +107.8% |
| Q3 FY2024 | Sep 30, 2024 | $963.86K | +709.9% |
| Q2 FY2024 | Jun 30, 2024 | $963.86K | +815.9% |
| Q1 FY2024 | Mar 31, 2024 | $963.86M | +541108.8% |
| Q4 FY2023 | Dec 31, 2023 | $1.60M | +236.5% |
| Q3 FY2023 | Sep 30, 2023 | $119.01K | -76.6% |
| Q2 FY2023 | Jun 30, 2023 | $105.23K | -81.0% |
| Q1 FY2023 | Mar 31, 2023 | $178.09K | -77.5% |
| Q4 FY2022 | Dec 31, 2022 | $475.87K | -56.7% |
| Q3 FY2022 | Sep 30, 2022 | $507.92K | – |
| Q2 FY2022 | Jun 30, 2022 | $553.78K | – |
| Q1 FY2022 | Mar 31, 2022 | $790.48K | – |
| Q4 FY2021 | Dec 31, 2021 | $1.10M | – |
| Q3 FY2021 | Sep 30, 2021 | $0 | – |
| Q2 FY2021 | Jun 30, 2021 | $0 | – |
See a number that looks wrong?